X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Merck Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs MERCK LTD - Comparison Results

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE MERCK LTD SUVEN LIFE/
MERCK LTD
 
P/E (TTM) x 18.5 48.4 38.3% View Chart
P/BV x 4.1 7.3 55.4% View Chart
Dividend Yield % 0.6 0.4 145.6%  

Financials

 SUVEN LIFE   MERCK LTD
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
MERCK LTD
Dec-16
SUVEN LIFE/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs2511,060 23.7%   
Low Rs155623 24.9%   
Sales per share (Unadj.) Rs49.1632.4 7.8%  
Earnings per share (Unadj.) Rs9.745.7 21.3%  
Cash flow per share (Unadj.) Rs11.462.3 18.3%  
Dividends per share (Unadj.) Rs1.5011.00 13.6%  
Dividend yield (eoy) %0.71.3 56.6%  
Book value per share (Unadj.) Rs60.3388.8 15.5%  
Shares outstanding (eoy) m127.2816.60 766.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.11.3 310.4%   
Avg P/E ratio x20.918.4 113.4%  
P/CF ratio (eoy) x17.813.5 131.9%  
Price / Book Value ratio x3.42.2 155.5%  
Dividend payout %15.424.1 64.2%   
Avg Mkt Cap Rs m25,82513,969 184.9%   
No. of employees `0001.11.6 67.7%   
Total wages/salary Rs m6131,487 41.2%   
Avg. sales/employee Rs Th5,832.66,631.9 87.9%   
Avg. wages/employee Rs Th571.5939.2 60.9%   
Avg. net profit/employee Rs Th1,153.8479.4 240.7%   
INCOME DATA
Net Sales Rs m6,25310,498 59.6%  
Other income Rs m233242 96.0%   
Total revenues Rs m6,48510,741 60.4%   
Gross profit Rs m1,9821,135 174.6%  
Depreciation Rs m213276 77.4%   
Interest Rs m460-   
Profit before tax Rs m1,9551,102 177.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718343 209.2%   
Profit after tax Rs m1,237759 163.0%  
Gross profit margin %31.710.8 293.1%  
Effective tax rate %36.731.1 117.9%   
Net profit margin %19.87.2 273.6%  
BALANCE SHEET DATA
Current assets Rs m5,6226,410 87.7%   
Current liabilities Rs m1,1688,828 13.2%   
Net working cap to sales %71.2-23.0 -309.2%  
Current ratio x4.80.7 663.2%  
Inventory Days Days8158 141.2%  
Debtors Days Days3638 93.6%  
Net fixed assets Rs m3,3251,406 236.4%   
Share capital Rs m127166 76.7%   
"Free" reserves Rs m7,5476,286 120.1%   
Net worth Rs m7,6746,455 118.9%   
Long term debt Rs m140-   
Total assets Rs m9,1358,828 103.5%  
Interest coverage x43.2NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.71.2 57.6%   
Return on assets %14.08.6 163.4%  
Return on equity %16.111.8 137.1%  
Return on capital %26.017.1 152.5%  
Exports to sales %08.3 0.0%   
Imports to sales %021.0 0.0%   
Exports (fob) Rs mNA869 0.0%   
Imports (cif) Rs mNA2,209 0.0%   
Fx inflow Rs m5,066959 528.4%   
Fx outflow Rs m2,0012,612 76.6%   
Net fx Rs m3,065-1,653 -185.4%   
CASH FLOW
From Operations Rs m6991,070 65.3%  
From Investments Rs m-6-750 0.8%  
From Financial Activity Rs m-577-150 385.2%  
Net Cashflow Rs m116171 68.1%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 0.0 18.2 -  
FIIs % 0.0 1.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 29.1 125.4%  
Shareholders   37,287 28,591 130.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   GLENMARK PHARMA  FULFORD INDIA  WYETH LTD  DIVIS LABORATORIES  UNICHEM LAB  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Down 1%; Realty, Auto Stocks Tank(12:30 pm)

After opening the day flat share markets in India are trading on a negative note and are presently trading below the dotted line.

Related Views on News

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Sep 24, 2018 01:49 PM

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS